Founded in 1888, AMBEV S.A. (ABEV), also known as Companhia de Bebidas das Americas, holds a prominent place in the global beverages industry. Headquartered in Sao Paulo, Brazil, the company is one of the largest brewers in the world. AMBEV maintains its competitive edge through an extensive portfolio of beverages, including beers, carbonated soft drinks, and non-alcoholic beverages.
Currently, AMBEV operates in 14 countries in the Americas and its portfolio includes iconic brands like Brahma, Antarctica, Skol, Stella Artois, and Budweiser. Despite its international presence, the company still exhibits a strong grounding in its Brazilian roots, upholding a cultural significance in the Brazilian market.
Although known primarily for its impressive beer portfolio, AMBEV's range of beverages extends beyond this. The company also produces and sells bottled water, isotonic beverages, energy drinks, iced teas, and ready-to-drink teas. This extensive portfolio solidifies AMBEV's position as a comprehensive beverages company, not just a brewer.
AMBEV S.A. has a powerful global presence through its strategic partnerships and alliances. The company is a part of the Anheuser-Busch InBev (AB InBev) conglomerate, which is regarded as the largest beer company globally. With around 100,000 employees, AMBEV effectively contributes to the conglomerate's operations across the globe.
Financially, AMBEV has been a consistent performer over the years. Despite encountering challenges such as increased competition, fluctuating exchange rates, and varying commodity prices, the company manages to register solid performance, exhibiting healthy margins and sustainable growth.
Beyond its economic contributions, AMBEV is notable for its strong commitment towards social, environmental, and governance (ESG) issues. The company aims to develop smart drinking habits, improve environmental sustainability, creating a healthier world for people by 2025.
In conclusion, AMBEV S.A. remains a formidable player in the global beverages market. Combining a wide-ranging portfolio with rigorous financial performance and a commitment to corporate social responsibility, the company is certainly not just a profitable investment opportunity but is also committed towards creating a sustainable and healthier world.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Ambev (NYSE:ABEV) was downgraded by Wall Street Zen to a "hold" rating from "buy," reflecting a cautious analyst outlook. The company's recent quarterly EPS matched expectations at $0.05, but revenue of $4.17 billion fell short of consensus estimates, with profit declining 10% year over year. Despite a share repurchase program designed to support per-share value, several firms, including Barclays and Bank of America, have lowered price targets or downgraded the stock, resulting in an average rating of "Reduce" and a consensus target price of $3.01.
Ambev reported third-quarter fiscal 2026 results with organic revenue growth of 7.6%, normalized EBITDA up 8.9%, and EPS rising 15.4%. Despite these gains, shares fell about 5% due to missing consensus expectations. The company's profitability is considered solid despite near-term market volatility.
Ambev S.A. (ABEV) stock has fallen over 3% after Bank of America downgraded it from Neutral to Underperform, citing concerns over weakening beer demand, weak operating trends, and a tough future cost outlook. The bank maintained a $3.30 price target, noting that the stock was trading at a premium valuation following a post-election rally in Brazil. Analysts believe that even lower interest rates will provide only limited upside for Ambev in the current macroeconomic environment.
Ambev S.A. published its slide deck in conjunction with its Q3 2026 earnings call, where the company reported an EPS of $0.05, beating expectations by $0.00. Revenue reached $4.01 billion, marking a 3.44% year-over-year increase, though it missed analyst estimates by $43.18 million. This presentation provides details on the company's financial performance for the quarter.
Ambev (ABEV) is projected to announce its Q3 2026 earnings before the market opens on Thursday, October 29th, with analysts forecasting earnings of $0.05 per share and revenue of $4.16 billion. The company recently declared a quarterly dividend of $0.0092 per share, and analysts currently hold a "Reduce" rating with a consensus target price of $3.13. Insider transactions show two directors sold shares in July and September.
Formuepleje A S recently acquired over 8 million shares of Ambev S.A. (NYSE:ABEV) worth approximately $23.6 million, making it their 13th largest holding. Despite this significant investment, analyst sentiment for Ambev remains cautious with an average "Reduce" rating and a consensus price target of $3.13. Ambev's latest quarterly earnings met EPS expectations but fell short on revenue.